Idera up as IMO-2055 deal ends

Idera Pharmaceuticals Inc. (NASDAQ:IDRA) gained $0.17 (15%) to $1.31 on Wednesday as it regained rights to cancer product IMO-2055 following the termination of a 2007 deal with Merck KGaA (Xetra:MRK)....